Sympathetic denervation blocks blood pressure elevation in episodic hypoxia.
about
Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoeaIntermittent hypoxia: a low-risk research tool with therapeutic value in humansPeripheral chemoreception and arterial pressure responses to intermittent hypoxiaHypoxia-inducible factors and hypertension: lessons from sleep apnea syndromeChronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approachSympathoexcitation and arterial hypertension associated with obstructive sleep apnea and cyclic intermittent hypoxiaRole of the sympathetic nervous system in carbon tetrachloride-induced hepatotoxicity and systemic inflammationEvolution and physiology of neural oxygen sensingThe efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions.Pathophysiology of sleep apneaEffect of AT1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction.Obstructive sleep apnea and type 2 diabetes: is there a link?Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: role of the angiotensin II type 1 receptor.The effects on cardiovascular autonomic control of repetitive arousal from sleepSLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELSA new rodent model for obstructive sleep apnea: effects on ATP-mediated dilations in cerebral arteriesCPAP versus oxygen in obstructive sleep apneaEffect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice.Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activityInvited review: Physiological and pathophysiological responses to intermittent hypoxia.Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure.Intermittent hypoxia: cell to system.Sleep apnea and cardiovascular disease.Chronic infusion of angiotensin receptor antagonists in the hypothalamic paraventricular nucleus prevents hypertension in a rat model of sleep apneaIntermittent hypoxia: cause of or therapy for systemic hypertension?Endothelial nitric oxide synthase uncoupling: a novel pathway in OSA induced vascular endothelial dysfunction.Sleep apnea and hypertension.Therapeutic potential of intermittent hypoxia: a matter of dose.Intermittent hypoxia-induced sensitization of central chemoreceptors contributes to sympathetic nerve activity during late expiration in ratsOxygen-sensing neurons in the central nervous system.Effects of chronic intermittent asphyxia on haematocrit, pulmonary arterial pressure and skeletal muscle structure in rats.Physiological and pathophysiological interactions between the respiratory central pattern generator and the sympathetic nervous system.Risk of Cerebrovascular Diseases After Uvulopalatopharyngoplasty in Patients With Obstructive Sleep Apnea: A Nationwide Cohort StudyChronic intermittent hypoxia exposure improves left ventricular contractility in transgenic mice with heart failure.Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target?Blood Pressure Increases in OSA due to Maintained Neurovascular Sympathetic Transduction: Impact of CPAP.Sleep apnoea and hypertension: role of chemoreflexes in humans.Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea.Molecular mechanisms of chronic intermittent hypoxia and hypertensionMolecular signatures of obstructive sleep apnea in adults: a review and perspective.
P2860
Q26783727-F6D37727-FDFD-4687-B722-E38F47401440Q26824915-958ED109-96A1-4484-BDA4-D614E2EAC82FQ26996367-498E8604-2BF0-40CF-BAA0-2A4001FF918BQ27026931-EF6FFE59-931E-4499-BE49-322581B7854FQ28076146-08F25AA0-7499-42D1-95C1-F7A1518AD392Q28088502-8A5481B8-903F-4EE0-BA64-CA69473658F8Q28544866-CA3FD1FF-2D9B-4FF5-A903-908588FE6C72Q28654648-5A9F83CD-E509-4823-B3D6-9299CD992C2BQ30428971-1AD915A6-F60B-4BB2-ADDF-714EB58808E7Q30440658-BCA86585-38B3-401F-9DAC-68DBA3A25FD8Q30450801-5270D61A-FACC-4C0B-BB43-4537913904C0Q30463385-AC11BD02-D5DE-421A-9855-7C792F95A215Q30475820-5622FD79-4C4C-4654-AB97-D34578F96055Q30494081-22A7334B-A961-4E05-9B96-772C4C59DE88Q30494316-BEEBD14C-659D-4538-A3F1-7337FB7BBAECQ30557443-D2B23D11-6B9B-4CCB-9BE9-4CC6481ACA25Q30587460-9DCF43E0-F8F7-44C8-AADD-59B48E920AFDQ33756050-EBA713BA-9709-4752-9ECA-CC081979EFCBQ33976445-E0CE0D74-9562-4798-AF1A-71C63B1C435BQ34180365-0BD7F705-B127-444D-85D6-26AD13C4B6CBQ34180371-99A02BC7-D7BA-4D67-AD91-C60F88CBFDDFQ34336970-EA7336FF-3AA1-4DA8-8838-31ED13489D1AQ34467343-0F713234-83FB-4CFD-ABF7-25CA6F765950Q34477161-41C512D6-A1DD-4D9C-B1C7-CC2C6974B3D0Q34769610-C124A5A7-D5F2-4287-986D-FE0B23C9713BQ34980336-77B86E4D-D51A-4060-BE27-83FE597A9C64Q35013799-770A82D2-9CAD-4699-B23C-61D9217B1DBCQ35043452-9C64AAFA-12BE-4AED-9237-D0022606CADBQ35055945-A7EE8D3E-2C85-4B65-BBBD-BE8ED0137B58Q35602028-141C4AA0-5C9E-4007-A0C6-32D0EC3FC5EBQ35756264-D77AB762-0922-4381-AE90-3466EA1D388BQ35882854-F1EF0161-E4A6-4D9B-BA1D-16D6AB4605DDQ36195672-9245598F-8363-4CF7-A42C-45A2F69F114DQ36320864-7F632D4A-713A-41CF-A180-4BDEF145141DQ36323458-B64D88FD-3593-4332-86A8-ADED30E84BD2Q36340657-4A6024E4-B293-44EA-9A20-E938ED874401Q36651043-FDD3182F-C4A2-4973-AEA0-376188668B0FQ36662363-33ED9986-0C07-45E0-B253-8809F47FB324Q36790835-CE7CF0F5-4E89-4D0D-8427-28B90720B2A4Q37146506-23FD7F0F-123E-4BEA-B79B-658FB7C3CF47
P2860
Sympathetic denervation blocks blood pressure elevation in episodic hypoxia.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Sympathetic denervation blocks blood pressure elevation in episodic hypoxia.
@en
type
label
Sympathetic denervation blocks blood pressure elevation in episodic hypoxia.
@en
prefLabel
Sympathetic denervation blocks blood pressure elevation in episodic hypoxia.
@en
P2093
P356
P1433
P1476
Sympathetic denervation blocks blood pressure elevation in episodic hypoxia.
@en
P2093
P304
P356
10.1161/01.HYP.20.5.612
P407
P50
P577
1992-11-01T00:00:00Z